Trial intelligence / Profile preview

Pirrotinib real-world study in HER2-positive or HER2-mutated solid tumors

ChiCTR2000039663Phase 4Recruiting

Sponsor

The First Affiliated Hospital of Guangxi Medical University

Start

Nov 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1